Physician profile
Brian Stephens
NPI 1760485718
$313.52
in general payments reported to CMS, 2019-2025
10 companies · $68.12 in 2025
The $68.12 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2025: $68.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $68.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $68.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $66.06 | 2019 | |
| Allergan, INC. | $58.92 | 2019 | |
| Hologic Sales and Service, LLC | $55.89 | 2019-2025 | Novasure, Acessa Provu System |
| Abbvie INC. | $35.75 | 2019 | |
| Sumitomo Pharma America, INC. | $25.26 | 2025 | Myfembree |
| Roche Diagnostics Corporation | $21.12 | 2019 | |
| Therapeuticsmd, INC. | $13.99 | 2019 | |
| Daiichi Sankyo INC. | $13.84 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.70 | 2019 | |
| Amgen INC. | $10.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Stephens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.